SARAH FORD-SIGHTLER: Open Payments
NPI 1396983987 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 53 payments from 16 companies in 2025. Trend: 2023 $1,456 · 2024 $1,384 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 12 | $335 |
| Otsuka America Pharmaceutical, Inc. | 7 | $194 |
| Travere Therapeutics, Inc. | 9 | $186 |
| Apellis Pharmaceuticals, Inc. | 3 | $79 |
| Novo Nordisk Inc | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Fresenius USA Marketing, Inc. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Amgen Inc. | 2 | $32 |
| Recor Medical Inc | 1 | $31 |
Products named: TARPEYO, JYNARQUE, Ozempic, FARXIGA, VELPHORO, Empaveli, Kerendia, TAVNEOS.
Industry payments across SC — which companies pay providers there.
